Karen E. D' Orazio
FDA investigator
Appears on 1 document from 2013, mostly at sites in New Jersey. Most often cites stability testing (21 CFR 211.166(b)).
- 1
- Documents on file
- 3.0
- Observations per 483
- 2013
- First seen
- 2013
- Most recent
What they cite most
From 3 observations- 21 CFR 211.166(b)Stability testing1
- 21 CFR 211.28(a)Personnel responsibilities1
- 21 CFR 211.42(c)(10)(iv)Design and construction features1
Activity by year
2013: 1
Where
New Jersey 1
Often inspects with
Is Karen E. D' Orazio coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
1 document, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2013-03-21 | 483 Drugs are Us, Inc. (dba Hopewell Pharmacy)Mar 21, 2013 · Hopewell, New Jersey | Hopewell, New Jersey | 3 |
About this profile
What does Karen E. D' Orazio inspect?
Karen E. D' Orazio appears on 1 document on file covering 1 site, mostly in New Jersey.
What do they cite most often?
21 CFR 211.166(b) (stability testing), followed by 21 CFR 211.28(a) and 21 CFR 211.42(c)(10)(iv).
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Karen E. D' Orazio is dated Mar 21, 2013.